Sphingosine‐1‐phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy
暂无分享,去创建一个
D. Hishikawa | M. Sugiyama | Y. Osawa | H. Shindou | D. Okuzaki | Taizo Mori | Sachiyo Yoshio | T. Kanto | K. Yanaga | M. Kage | Y. Sakamoto | M. Tamura-Nakano | Toru Ikegami | Taiji Yamazoe | Miku Okawara | Hironari Kawai | Y. Tsutsui | Y. Yoshida | Shiori Yoshikawa | H. Kusano | H. Komatsu | Keisuke Yanagida | M. Matsuda | Tomonari Shimagaki | A. Inui | H. Doi | Tomoyuki Tsunoda | Chinatsu Oyama | Kana Hashi | K. Yanagida | Hironori Kusano
[1] Y. Osawa,et al. Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy , 2021, Hepatology communications.
[2] K. Moore,et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming , 2020, Nature Medicine.
[3] Y. Iwakiri,et al. Endothelial Leukocyte Cell–Derived Chemotaxin 2/Tyrosine Kinase With Immunoglobulin‐Like and Epidermal Growth Factor–Like Domains 1 Signaling in Liver Fibrosis , 2020 .
[4] J. Scoazec,et al. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis , 2019, Hepatology.
[5] Dalei Wu,et al. LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis , 2019, Cell.
[6] P. Rautou,et al. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. , 2019, Journal of hepatology.
[7] Y. Osawa,et al. Liver disease secondary to congenital heart disease in children , 2019, Expert review of gastroenterology & hepatology.
[8] S. Friedman,et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. , 2019, Journal of hepatology.
[9] M. Hattori,et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis , 2019, Nature Microbiology.
[10] M. Zeng,et al. The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis , 2019, Front. Pharmacol..
[11] V. Paradis,et al. Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome , 2018, Oncogene.
[12] Lyanne M. Kieneker,et al. Heart Failure Stimulates Tumor Growth by Circulating Factors , 2018, Circulation.
[13] K. Sakimura,et al. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis. , 2018, Cancer research.
[14] B. Ogretmen,et al. Sphingolipid metabolism in cancer signalling and therapy , 2017, Nature Reviews Cancer.
[15] J. Ladero,et al. Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[16] L. DeLeve,et al. Liver Sinusoidal Endothelial Cell: An Update , 2017, Seminars in Liver Disease.
[17] T. Suda,et al. Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets , 2017, Nature.
[18] J. González‐Gallego,et al. Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy , 2017, Front. Pharmacol..
[19] Lixin Sun,et al. The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice , 2017, Hepatology.
[20] K. Gauvreau,et al. Liver health in adults with Fontan circulation: A multicenter cross‐sectional study , 2017, The Journal of thoracic and cardiovascular surgery.
[21] S. Venkatesh,et al. Congestive hepatopathy , 2017, Abdominal Radiology.
[22] Richard Moreau,et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. , 2017, Journal of hepatology.
[23] N. Ferreirós,et al. Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma , 2016, Oncotarget.
[24] K. Hasegawa,et al. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence , 2016, PloS one.
[25] J. Pfeilschifter,et al. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo. , 2015, Circulation research.
[26] L. DeLeve. Liver sinusoidal endothelial cells in hepatic fibrosis , 2015, Hepatology.
[27] R. Ehman,et al. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces , 2015, Hepatology.
[28] P. Kamath,et al. Hepatocellular carcinoma after the Fontan procedure. , 2013, The New England journal of medicine.
[29] Raul Rabadan,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.
[30] G. Kanel,et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. , 2012, Gastroenterology.
[31] G. Karaca,et al. Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation , 2012, Gut.
[32] G. Giannelli,et al. Inhibiting TGF-β signaling in hepatocellular carcinoma. , 2011, Biochimica et biophysica acta.
[33] Hua Yu,et al. Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors , 2010, Nature Medicine.
[34] Shahin Rafii,et al. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors , 2010, Nature Reviews Cancer.
[35] R. Schwabe,et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.
[36] Y. Maehara,et al. High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma , 2006, Cancer science.
[37] G. Hutchins,et al. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. , 2005, The Journal of thoracic and cardiovascular surgery.
[38] G. Rogers,et al. Endotoxin-induced defenestration of the hepatic sinusoidal endothelium: a factor in the pathogenesis of cirrhosis? , 2008, Liver.
[39] F Braet,et al. Cell biology of liver endothelial and Kupffer cells. , 1994, Gut.
[40] F. Schaffner,et al. Chronic passive congestion of the liver in man. Electron microscopic study of cell atrophy and intralobular fibrosis. , 1967, The American journal of pathology.